Skip to navigation Skip to content

Fabry disease (FD) Program in Pharmaceutical Benefits Scheme (PBS) 012-24080524

Expand/Collapse all sectionsExpand all



This document outlines details of PBS-subsidised migalastat for patients with Fabry disease (FD).

For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.

Fabry disease (FD) quick reference

Restrictions

Authority level and section

PA assessment

Processing system

Prescriber type

Prescriber self-serve

Initial

PB373 form

Written

Electronic

S85:

migalastat

No

OPA

Must be treated by a:

  • physician with expertise in the management of Fabry disease

Yes - delayed assessment due to DPMQ (cost)

Grandfather

PB374 form

Written

Electronic

S85:

migalastat

No

OPA

Must be treated by a:

  • physician with expertise in the management of Fabry disease

Yes - delayed assessment due to DPMQ (cost)

Continuing

Telephone

Electronic

S85:

migalastat

No

OPA

Must be treated by a:

  • physician with expertise in the management of Fabry disease

Yes